Schonfeld Strategic Advisors LLC Cv Rx, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14 Billion
- Q1 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 188,673 shares of CVRX stock, worth $1.97 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
188,673
Previous 64,200
193.88%
Holding current value
$1.97 Million
Previous $2.02 Million
70.22%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CVRX
# of Institutions
91Shares Held
13.8MCall Options Held
264KPut Options Held
89.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$42.8 Million15.74% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$24.7 Million3.03% of portfolio
-
Black Rock Inc. New York, NY765KShares$7.98 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL619KShares$6.45 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$6.2 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $215M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...